Revenue

3 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Revenue

NOTE O – REVENUE

Disaggregation of revenue

Ashland disaggregates its revenue by segment and geographical region as Ashland believes these categories best depict how management reviews the financial performance of its operations. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation. See the following tables for details. See Note P for additional information.

Sales by geography
	Three months ended
	December 31
(In millions)	2023		2022
Life Sciences
North America	$	67	$	47
Europe		63		74
Asia Pacific		51		60
Latin America & other		19		26
	$	200	$	207
	Three months ended
	December 31
(In millions)	2023		2022
Personal Care
North America	$	40	$	42
Europe		47		51
Asia Pacific		25		28
Latin America & other		17		17
	$	129	$	138
	Three months ended
	December 31
(In millions)	2023		2022
Specialty Additives
North America	$	42	$	53
Europe		40		48
Asia Pacific		34		35
Latin America & other		6		7
	$	122	$	143
	Three months ended
	December 31
(In millions)	2023		2022
Intermediates
North America	$	25	$	34
Europe		4		9
Asia Pacific		3		8
Latin America & other		1		3
	$	33	$	54

Trade receivables

Trade receivables are defined as receivables arising from contracts with customers and are recorded within the accounts receivable caption within the Condensed Consolidated Balance Sheets. Ashland’s trade receivables were $161 million and $288 million as of December 31, 2023 and September 30, 2023, respectively. See Note G for additional information on Ashland’s programs to sell certain receivables on a revolving basis to third party banks up to an aggregate purchase limit (U.S and Foreign Accounts Receivable Sales Programs).